{
    "nct_id": "NCT05605964",
    "official_title": "Relugolix Versus Leuprolide in Patients With Prostate Cancer: A Randomized, Open-Label Study to Assess Major Adverse Cardiovascular Events (REPLACE-CV)",
    "inclusion_criteria": "A patient will be eligible for inclusion in the discontinuation phase of the study if the following applies:\n\n1. Was previously enrolled under the original version and amendment 1 of this study\n2. Has voluntarily resigned and dated the informed consent form prior to transition to the discontinuation phase of this study\nHealthy volunteers allowed\nMust be MALE\nMust have minimum age of 18 Years",
    "exclusion_criteria": "",
    "miscellaneous_criteria": ""
}